Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients

NCT05537948 is registered in ClinicalTrials.gov with National Medical Research Center for Therapy and Preventive Medicine as lead sponsor.

NCT NCT05537948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05537948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients
Lead sponsor
National Medical Research Center for Therapy and Preventive Medicine
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 1, 2021
Completion date
January 31, 2025
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias, hydroxymethylglutaryl-coa reductase inhibitors, hyperlipidemias, immunosuppression, liver transplant disorder, statins